lisocabtagene maraleucel

lisocabtagene maraleucel

lisocabtagene maraleucel U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol-Myers Squibb’s Biologics License Application (BLA) for Lisocabtagene Maraleucel (liso-cel) for Adult Patients…

Read More